High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis
Open Access
- 26 February 2007
- journal article
- other
- Published by Wolters Kluwer Health in Hepatology
- Vol. 45 (3) , 831-832
- https://doi.org/10.1002/hep.21601
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosisHepatology, 2006
- Consensus on extra‐hepatic portal vein obstructionLiver International, 2006
- Budd-Chiari Syndrome and Portal Vein Thrombosis Associated with Myeloproliferative Disorders: Diagnosis and ManagementSeminars in Thrombosis and Hemostasis, 2006
- Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosisBritish Journal of Haematology, 2005
- Bone marrow biopsy morbidity: review of 2003: Table 1Journal of Clinical Pathology, 2005
- Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapyGastroenterology, 2001
- Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factorsHepatology, 2000
- Spontaneous Erythroid Colony Formation as the Clue to an Underlying Myeloproliferative Disorder in Patients with Budd-Chiari Syndrome or Portal Vein ThrombosisSeminars in Thrombosis and Hemostasis, 1997